共 37 条
[1]
Hodgkinson AD(2001)Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy Kidney Int 60 211-218
[2]
Søndergaard KL(1996)Oxidative stress and diabetic vascular complications Diabetes Care 19 257-267
[3]
Yang B(1988)Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy N Engl J Med 319 542-548
[4]
Giugliano D(1992)Complications: neuropathy, pathogenetic considerations Diabetes Care 15 1902-1925
[5]
Ceriello A(1966)Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes Science 151 209-210
[6]
Paolisso G(1997)Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats Diabetologia 40 271-281
[7]
Dyck PJ(2000)Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients Diabetes Care 23 1539-1544
[8]
Zimmerman BR(2010)Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 33 2285-2293
[9]
Vilen TH(2016)Glucotoxic mechanisms and related therapeutic approaches Int Rev Neurobiol 127 121-149
[10]
Greene DA(2017)New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain Neuron 93 1296-1313